Promising New Cancer Screening Methods

Promising new cancer screening methods are pivoting toward multi-cancer early detection (MCED) blood tests (liquid biopsies) and AI-enhanced imaging, which aim to detect multiple cancer types from a single, non-invasive sample, often before symptoms arise. These technologies, including the Galleri test and Novelna's protein-based tests, analyze DNA, proteins, or methylation patterns to identify cancer signals.

Multi-Cancer Early Detection (MCED) Blood Tests: These tests, often called liquid biopsies, detect DNA or proteins shed by cancer cells into the bloodstream, identifying early-stage cancers (e.g., ovarian, pancreatic) that lack standard screening protocols.
- Galleri Test: Analyzes chemical methylation patterns to detect over 50 types of cancer, with the potential to indicate the cancer's origin in the body.
- Novelna's Test: An experimental test analyzing protein signatures, showing high accuracy in identifying 18 early-stage cancers, including 93% of stage 1 cancers in men.
- TriOx Test: A new, Oxford-developed test showing high sensitivity in detecting trace cancer DNA.
AI and Machine Learning in Screening: AI is enhancing existing imaging techniques (e.g., mammography) to improve accuracy and efficiency in reading scans, reducing false positives.
Other Liquid Biopsies: Research into analyzing blood, breath, and urine for early signs of cancer, offering a less invasive alternative to tissue biopsies.

While offering immense promise for reducing cancer mortality, many of these technologies, including MCED, are still in research or early implementation phases, and they can produce false positives.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(447)

L.A.T.E. A New Dementia (take two)

This week on PodcastDX, we're talking about L.A.T.E., which stands for Limbic-predominant Age-related TDP-43 Encephalopathy. It's a type of dementia that many people have never heard of, but it's comm...

27 Loka 34min

L.A.T.E.L.A.T.E., Limbic-predominant-Age-related-TDP-43-Encephalopathy

27 Loka 34min

Social Media Health Advice- How Do You Vet It?

Welcome to PodcastDx, the show that helps you make sense of your health. I'm Jean Marie McNamara. I'm joining you today with Lita Tomas, our Production Manager and of our co-hosts, Ron Rispoli (our t...

20 Loka 18min

Fatigue in Ehlers Danlos

Fatigue is more than feeling tired—for many people living with Ehlers-Danlos syndromes (EDS), it can mean overwhelming physical and mental exhaustion that affects even the simplest daily tasks. Chroni...

13 Loka 16min

Product Recalls (AGAIN!) and Your Health

This week we will discuss product recalls and your health. According to WEBMD: A product safety recall happens when a consumer watch group or a manufacturer finds problems with a product. Lots of ite...

15 Syys 15min

Stage 4 Cancer as an ER Doc

Our guest today is a physician, author and activist. The topic this week is "Stage 4 Cancer as an ER Doc". Dr. James Maskalyk practices emergency medicine at St. Michael's, Toronto's inner-city tr...

8 Syys 1h 3min

Ai and Robotics in Medicine

This week on PodcastDX, Dr. Sanjeev Kumar joins Lita, Ron, and Jean Marie to discuss AI and robotics in medicine—from surgical robots and rehabilitation technology to hospital automation, patient safe...

1 Syys 47min

EECP The Most Underutilized Therapy in Medicine

Retired U.S. Coast Guard Master Chief Petty Officer Jack Clifford joins PodcastDX to share how severe chronic angina once limited even everyday activities and left him facing the possibility of triple...

25 Elo 44min